AMENDMENT TO THE SPONSOR SUPPORT AGREEMENTSponsor Support Agreement • May 3rd, 2024 • TenX Keane Acquisition • Pharmaceutical preparations
This Amendment (the “Amendment”), dated as of April 26, 2024, to the Sponsor Support Agreement, dated October 23, 2023 (the “Sponsor Support Agreement”), is entered into by and between 10XYZ Holdings LP, a Delaware limited partnership (“Sponsor”), TenX Keane Acquisition, a Cayman Islands exempted company (which will migrate to and domesticate as a Delaware corporation prior to the Closing) (“Parent”), Citius Pharmaceuticals, Inc., a Nevada corporation (the “Company”), and Citius Oncology, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“SpinCo”) and Intelligent Investment I LLC (“3I”). Each of the foregoing parties is referred to herein as a “Party” and collectively as the “Parties.” Capitalized terms used herein but not defined shall have the meaning set forth in the Sponsor Support Agreement.
CONTRIBUTION AGREEMENTContribution Agreement • May 3rd, 2024 • TenX Keane Acquisition • Pharmaceutical preparations
THIS CONTRIBUTION AGREEMENT (the “Agreement”), effective as of April 1, 2022 (the “Effective Date”), by and between Citius Pharmaceuticals, Inc. (“Contributor”), and Citius Acquisition Corp., a Delaware corporation (the “Corporation”).
